CorDynamics is the only CRO dedicated to answering your cardiovascular toxicology and safety pharmacology questions for your lead compound today—rather than reacting tomorrow.
Investigating cardiac toxicity—the industry’s most pressing issue—is our specialty. From lead optimization in drug discovery to GLP, CorDynamics offers comprehensive cardiovascular toxicology and safety pharmacology studies.
Our proven techniques, unparalleled timelines and customized approaches are designed to fit seamlessly into your preclinical drug development workflow. Our cardiovascular researchers work in conjunction with your project teams interpreting previous data, collaborating on de-risking strategies and executing regulatory-compliant examinations.
Our cardiovascular studies leverage the isolated Langendorff heart, anesthetized models and conscious telemetry subjects to investigate:
- Prolonged QT Interval
- Heart Rate
- Blood Pressure
- Cardiac Function
Looking for more information on our drug development research? Delve into our publications or contact us directly to start a discussion.